Rendy Hosea

460 total citations · 1 hit paper
10 papers, 292 citations indexed

About

Rendy Hosea is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rendy Hosea has authored 10 papers receiving a total of 292 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Rendy Hosea's work include RNA modifications and cancer (3 papers), interferon and immune responses (2 papers) and Cancer-related molecular mechanisms research (2 papers). Rendy Hosea is often cited by papers focused on RNA modifications and cancer (3 papers), interferon and immune responses (2 papers) and Cancer-related molecular mechanisms research (2 papers). Rendy Hosea collaborates with scholars based in China, Japan and Indonesia. Rendy Hosea's co-authors include Vivi Kasim, Shourong Wu, Septelia Inawati Wanandi, Osamu Ohneda, Makoto Miyagishi, Yanjun Li, Xinxin Luo, Wei Duan, Guanbin Song and Juan Li and has published in prestigious journals such as International Journal of Molecular Sciences, PLoS Genetics and Advanced Science.

In The Last Decade

Rendy Hosea

10 papers receiving 286 citations

Hit Papers

The two sides of chromosomal instability: drivers and bra... 2024 2026 2025 2024 20 40 60

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rendy Hosea China 9 178 109 88 49 46 10 292
Haijun Tang China 8 178 1.0× 94 0.9× 68 0.8× 51 1.0× 37 0.8× 16 285
Yaozhen Pan China 7 176 1.0× 92 0.8× 91 1.0× 44 0.9× 46 1.0× 22 284
Jeannette Huaman United States 6 155 0.9× 111 1.0× 73 0.8× 49 1.0× 48 1.0× 7 310
Faying Xu China 4 289 1.6× 115 1.1× 105 1.2× 41 0.8× 36 0.8× 6 391
Yingxia Ning China 10 212 1.2× 147 1.3× 109 1.2× 29 0.6× 49 1.1× 20 354
Liang Song China 10 193 1.1× 112 1.0× 62 0.7× 71 1.4× 39 0.8× 26 293
Pengyu Jing China 11 309 1.7× 112 1.0× 94 1.1× 59 1.2× 42 0.9× 23 417
Jingyi Han China 11 232 1.3× 141 1.3× 64 0.7× 61 1.2× 57 1.2× 18 373
Shamin Rezaei Iran 6 220 1.2× 160 1.5× 73 0.8× 49 1.0× 33 0.7× 8 319
Mingdian Lu China 9 198 1.1× 101 0.9× 45 0.5× 50 1.0× 26 0.6× 15 271

Countries citing papers authored by Rendy Hosea

Since Specialization
Citations

This map shows the geographic impact of Rendy Hosea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rendy Hosea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rendy Hosea more than expected).

Fields of papers citing papers by Rendy Hosea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rendy Hosea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rendy Hosea. The network helps show where Rendy Hosea may publish in the future.

Co-authorship network of co-authors of Rendy Hosea

This figure shows the co-authorship network connecting the top 25 collaborators of Rendy Hosea. A scholar is included among the top collaborators of Rendy Hosea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rendy Hosea. Rendy Hosea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hosea, Rendy, Fuqiang Zhao, Jingyi Liu, et al.. (2025). Chromosome Missegregation Triggers Tumor Cell Pyroptosis and Enhances Anti‐Tumor Immunotherapy in Colorectal Cancer. Advanced Science. 12(12). e2409769–e2409769. 3 indexed citations
2.
Hosea, Rendy, et al.. (2024). The two sides of chromosomal instability: drivers and brakes in cancer. Signal Transduction and Targeted Therapy. 9(1). 75–75. 72 indexed citations breakdown →
3.
Hosea, Rendy, et al.. (2024). YY2/BUB3 Axis promotes SAC Hyperactivation and Inhibits Colorectal Cancer Progression via Regulating Chromosomal Instability. Advanced Science. 11(26). e2308690–e2308690. 9 indexed citations
4.
Hosea, Rendy, et al.. (2023). NeuroD1-GPX4 signaling leads to ferroptosis resistance in hepatocellular carcinoma. PLoS Genetics. 19(12). e1011098–e1011098. 9 indexed citations
5.
Hosea, Rendy, et al.. (2023). Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions. Cancers. 15(13). 3506–3506. 34 indexed citations
6.
Hosea, Rendy, et al.. (2023). The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers. International Journal of Molecular Sciences. 24(24). 17238–17238. 15 indexed citations
7.
Li, Juan, Xinxin Luo, Rendy Hosea, et al.. (2023). YY2‐DRP1 Axis Regulates Mitochondrial Fission and Determines Cancer Stem Cell Asymmetric Division. Advanced Science. 10(23). e2207349–e2207349. 19 indexed citations
8.
Hosea, Rendy, et al.. (2020). The biological implications of Yin Yang 1 in the hallmarks of cancer. Theranostics. 10(9). 4183–4200. 92 indexed citations
9.
Wanandi, Septelia Inawati, et al.. (2018). Metabolic Interplay between Tumour Cells and Cancer-Associated Fibroblasts (CAFs) under Hypoxia versus Normoxia. Malaysian Journal of Medical Sciences. 25(3). 7–16. 20 indexed citations
10.
Hosea, Rendy, et al.. (2018). Glucosamine decreases the stemness of human ALDH+ breast cancer stem cells by inactivating STAT3. Oncology Letters. 16(4). 4737–4744. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026